糖尿病基础知识胰岛素发展史.pptVIP

* 联合诺和锐及诺和平为理想的强化治疗方法，但每日注射次数较多。为了依从性更好，减少注射次数，生产出胰岛素类似物的混合制剂 * 预混胰岛素类似物诺和锐?30与预混人胰岛素30R的区别在于: 诺和锐?30中含有是30%的门冬胰岛素和70%的精蛋白结合的结晶门冬胰岛素 预混人胰岛素30R中含有的是30%的可溶性人胰岛素和70%的中效胰岛素(NPH),正是由于它们预混成份的不同使得它们在药代及药效学上有着明显的区别. * * The favourable insulin profile demonstrated for NovoMix? 30 in pharmacological studies results in reduced glucose exposure and improved glycaemic control in patients with diabetes in clinical practice. The efficacy and safety of NovoMix? 30 and premixed human insulin were compared in a population of 294 insulin-treated patients with either type 1 or type 2 diabetes, who received NovoMi